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Chapter 2 
 
Literature review 
 
 
2.1 Oral cancer 
 
2.1.1 Definition  
 
 Oral cancer is a malignant neoplasm involving the lips, tongue, floor of mouth, 
gingival/alveolus (gum) and alveolus, palate and buccal mucosa (C00-C06). These defined 
oral cancer sites were based on the World Health Organization (WHO), International 
Classification of Diseases: tenth edition (ICD-10). The most common form of intra-oral 
malignancy is squamous cell carcinoma (Blot et al., 1992; Zakrzewska, 1999).  
 
2.1.2 Epidemiology of oral cancer 
 
Worldwide, oral cancer is ranked 11th most common malignancy 
(Sankaranarayanan, 2003). It accounted for about 274,000 cases with estimated mortality 
rate of about 127,000 deaths in the year 2002. Of these figures, two-thirds of which 
occurred in the developing countries (Parkin et al., 2005). In many parts of Asia, oral 
cancer continues to be a major health problem. The occurrences of oral cancer are 
dominated by countries in southern Asia, South-East Asia and Melanesia region (Johnson, 
2003a). Oral cancer was reported as the most common site and accounts for about 40% of 
all cancers in India and Sri Lanka (Sankaranarayanan, 1990; Zakrzewska, 1999). However, 
in developed countries like United Kingdom (UK) and United States of America (USA), 
oral cancer only accounted for 1-2% of all cancers detected (Zakrzewska, 1999; Jemal et 
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al., 2007). Despite the low prevalence in the UK, more than 50% of oral cancer results in 
deaths (Zakrzewska, 1999).  
 
In Malaysia, the second report of the National Cancer Registry (NCR) data 
revealed that a total of 21,464 cancer cases were diagnosed among Malaysians in 
Peninsular Malaysia in the year 2003 (Lim and Halimah, 2004). In this report, oral cancers 
were recorded separately into the lip, mouth and tongue cancers. Among the males, mouth 
and tongue cancers were ranked 19th and 17th respectively of all cancers in Malaysia. 
Meanwhile among the females, mouth and tongue cancers were ranked 16th and 21st 
respectively of all cancers. When both mouth and tongue cancers were taken together, 
cancers of the oral cavity would account for 2.5% of male cancers and 2% of female 
cancers making it the 12th commonest cancer among men and the 13th most common 
cancer among women.  
 
NCR also reported that the age specific incidence rate (ASR) for both mouth and 
tongue cancers increased with age. With regards to ethnicity, Indians have a higher 
incidence of mouth cancers than the other races. In fact, the Indian females had the highest 
incidence of mouth cancers with an ASR of 16.5 per 100,000 of the population. Among 
Indian males, mouth and tongue cancers were ranked 6th (5.2%) and 9th (4.4%) respectively 
of all cancers. Meanwhile, mouth and tongue cancers were ranked 3rd (7.7%) and 9th 
(3.1%) respectively of all cancers among Indian females. When both mouth and tongue 
cancers were combined, they account for 9.6% of Indian male cancers making it the most 
common cancer among men and the 3rd most common cancer among Indian women 
(10.8%). NCR further described when comparing between the Indians and Malays, Indians 
were found to have 8.8 times the incidence of male mouth cancer, and 28.3 times the 
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incidence of female mouth cancer. With regards to tongue cancers, Indians had the highest 
incidence rate of tongue cancers which was 6.2 times the Malay male incidence and 11.3 
times the Malay females. 
 
Based on the Annual Report 1996 from the Ministry of Health, quoted by Zain and 
Ghazali (2001), lip and oral cancer were the third most common cancer deaths in 
government hospitals. In fact, this malignancy accounted for 7.1% of cancer deaths 
reported from the facilities of the Ministry of Health. Although prevalence of oral cancer is 
low in Malaysia at 0.04% (Zain et al., 1997), about 60% of oral cancer lesions have been 
found to occur among the Indian ethnic group who comprise only about 8% of the total 
Malaysian population (NCR, 2003). 
 
2.1.3 Molecular epidemiology 
 
Besides common epidemiological studies, quite a number of molecular 
epidemiology studies have also been conducted (London et al., 2000; Zhao et al., 2001; 
Seow et al., 2002; Wang et al., 2004). In a well-designed molecular epidemiological study, 
the risk associated with metabolic polymorphisms for oral cancer was assessed and so far 
have shown that the overall effect of common polymorphism is moderate in terms of 
relative risk (Nair and Bartsch, 2001). These type of studies also has enabled us to identify 
a number of carcinogenic hazards, and in some cases providing definitive etiologic data, 
besides furthering our understanding of individual genetic and acquired susceptibility to 
environmental carcinogens (Perera, 2003) and also development of oral cancer or oral 
carcinogenesis.  
 
 12 
2.1.4 Oral carcinogenesis 
 
Oral cancer is a multistep process in which multiple genetic events occur that alter 
the normal functions of oncogenes and tumor suppressor genes (Williams, 2000). The 
activation of oncogenes and the inactivation of tumor suppressor genes are the results of 
early genetic alterations that accompany phenotypic changes that occur in tumor 
progression (Kupferman and Myers, 2006). The consequences of this genetic damage are 
cell dysregulation with disruption in cell signaling, cell growth cycle, and/or mechanisms 
to repair cell damage or eliminate dysfunctional cells. It is the accumulation of such 
genetic changes, often over a period of time that becomes autonomous and with invasive 
mechanisms developed would lead to a carcinoma (Scully et al., 2000). Figure 2.1 
illustrates these events. 
 
 
Figure 2.1: Continuum of events between exposure and disease (cancer). 
(Source: Illustration based on concepts of molecular epidemiologic events from A 
Conceptual and Historical Framework for Molecular Epidemiology by Schulte, 1993). 
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 Cancers are often perceived as the outcome of a complex biological process. The 
stages of carcinogenesis consists of initiation which include the DNA damages to the cells 
or tissues as a result of exposure to carcinogens, followed by division of the exposed cells, 
such that their growth potential is changed irreversibly, and lastly progression indicating 
multiple rounds of cell replication mediating the gradual transition of an initiated cell 
towards autonomous cancerous growth (Figure 2.1). Metastasis represents the ultimate 
spread of malignant cells resulting in multiple tumor sites (Stewart, 2003). 
 
2.1.4.1 Oncogenes 
 
 Oncogenes are genes whose protein products have been found to be important for 
normal cell growth signaling and differentiation. However, over-expression or mutation of 
these genes leads to unchecked cell growth and tumorigenesis (Das and Nagpal, 2002). 
Mechanisms of activation of these cellular oncogenes include point mutations and DNA 
rearrangements (Wong et al., 1996). In oral cancer, some of the oncogenes involve are 
EGFR, STAT3 and K-RAS (Kupferman and Myers, 2006). 
 
2.1.4.2 Tumor suppressor genes 
 
Tumor suppressor genes, on the other hand, encode proteins that prevent normal 
cellular processes from going awry and are likely to be involved in regulating cell growth 
or differentiation, cell-cycle control, cell-cell adhesion, apoptosis and maintenance of 
genomic integrity (Fearon, 2002). In general, cells require only a single functioning copy 
of the tumor suppressor gene to maintain normal cellular homeostasis. However, when a 
cell undergoes loss of both alleles of a tumor suppressor gene locus, through deletion, 
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mutation, or epigenetic silencing, the loss of cell growth control become evident (Das and 
Nagpal, 2002). This process has since been observed for numerous tumor suppressor 
genes, including pRB, p16, p53, APC and BRCA (Kupferman and Myers, 2006). 
 
 
2.2 Risk factors 
 
 In general, oral cancer development is influenced by several risk factors either 
environmental or genetic associated. Some of the environmental risk factors include 
tobacco smoking, alcohol drinking, betel-quid chewing, radiation and diet. Meanwhile 
some of the genetic associated risk factors are viruses and genetic predisposition. Of these, 
major risk factors such as tobacco smoking and excessive alcohol consumption are very 
well established (Johnson, 2003b). From the estimates of relative risk for tobacco habit and 
alcohol abuse, it has been estimated that 75% of all oral cancers could be prevented 
(Walker et al., 2003). The primary cause of high incidence in Asians is the widespread 
habit of chewing betel-quid (Johnson, 2003b). In a separate study, Winn et al., (1991) 
found that the regular use of mouthwash with high alcohol content may also contribute to 
oral cancer risk. The risk was more apparent when the alcohol content of the mouthwash 
exceeded 25 percent. 
 
In the Malaysian context, a study done by Muttalib et al., (2002) revealed that a 
total of 44.5% of 6,781 subjects professed to one or more of the three ‘high-risk’ habits 
(namely tobacco smoking, alcohol drinking and betel-quid chewing). It was further 
discovered in his study that more than 22% of the locals studied practiced betel-quid 
chewing and 21.8% smoked. In fact, a higher proportion of females chewed betel-quid but 
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higher proportions of males smoked and consumed alcohol (Muttalib et al., 2002). In 
Taiwan, the risk factors for oral cancer were found to be very similar with the Malaysian 
population. Majority of the Taiwanese population also practiced the risk habits of cigarette 
smoking, alcohol drinking and betel-quid chewing (Hung et al., 1997).  
 
2.2.1 Tobacco smoking 
 
Tobacco smoking is the main known cause of human cancer-related death 
worldwide. In most developed countries, tobacco accounts for as much as 30% of all 
malignant tumors (Boffetta, 2003b). Tobacco smoking is the strongest risk factor for lung 
(Boyle and Maisonneuve, 1995) and oral cancer (Nair and Bartsch, 2001; Geisler and 
Olshan, 2001). Smoking of cigarette or bidi among the Indians has also shown to increase 
oral cancer risk. There is also a strong dose-response relationship found between the 
number of cigarettes smoked and the development of oral cancer (Vecchia et al., 1997; 
Geisler and Olshan, 2001; Reichart, 2001; Boffetta, 2003b). 
 
Generally, the content of a cigarette consists of compounds such as tar, nicotine and 
nitrosamines which vary greatly, depending on species, curing additives and method of 
combustion (Johnson, 2001). In Malaysia, types of tobacco smoking includes commercial 
brand cigarettes which are the most common form, ‘bidi’ mainly used by Indians, hand-
made paper-rolled cigarette (raw tobacco rolled in special paper prior to smoking), ‘rokok 
daun’ (raw tobacco rolled in temburna leaves prior to smoking) and kretek (an Indonesian 
imported type of cigarette containing spices such as cloves in addition to tobacco) (Zain 
and Ghazali, 2001).  
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Tobacco smoke contains a great number of chemical carcinogens (Boffetta, 2003b). 
The most important carcinogens and found abundantly in tobacco smoke are the polycyclic 
aromatic hydrocarbon benzo(α)pyrene and the tobacco specific nitrosamines (TSNs) 
namely 4-(nitrosomethylamino)-1-(3-pyridyl)-1-butanone (NNK) and N’-
nitrosonornicotine (NNN). These TSNs can induce specific mutations, especially 
guanidine-to-thymidine transversions, which interfere with DNA replication (Scully et al., 
2000; Johnson, 2001; Walker et al., 2003). The metabolism of these carcinogens involves 
oxygenation by P450 enzymes in cytochromes and conjugation by glutathione s-
transferase (GST). Some of these enzymes are polymorphic and strongly influence 
individual biological responses to carcinogens through their role in adduct formation 
(Scully et al., 2000). Therefore, genetic polymorphisms in the genes coding for these 
enzymes (for example GST) that result in increased carcinogen exposure may be the 
reason for individual susceptibility to cancer (Park et al., 1997; Johnson, 2001; Hashibe et 
al., 2003). 
 
To reflect on the Malaysian population, findings from the Second National Health 
and Morbidity Survey 1996 revealed that the prevalence of current smokers aged 18 and 
above was 24.8%. This survey also showed that the highest prevalence of current smokers 
was among the Malays and the male gender of indigenous people of Sabah and Sarawak 
who had low level of education and household income (Haniza et al., 1999). 
 
2.2.2 Alcohol drinking 
 
 Alcohol consumption has been strongly implicated as an independent risk factor in 
the development of oral cancer (Nair and Bartsch, 2001; Geisler and Olshan, 2001). Taken 
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together, alcohol consumption with tobacco smoking has been shown to act synergistically 
in increasing oral cancer risk (Blot, 1992; Reichart, 2001; Geisler and Olshan, 2001; Das 
and Nagpal, 2002; Kupferman and Myers, 2006). Johnson (2001) further reported that a 
poor diet together with the effects of tobacco smoking and heavy alcohol consumption had 
constituted over 90% of cases of head and neck cancer. Besides, these patients who 
diagnosed with oral cancer that were often exposed to tobacco and alcohol may also pose 
for higher risks of recurrences and second primary lesions (Kupferman and Myers, 2006). 
 
All forms of alcoholic drink are dangerous if heavily consumed. In fact, alcohol 
may lead to nutritional deficiencies which could increase the susceptibility to carcinogens 
and also lead to immune suppression (Das and Nagpal, 2002). Among the commonly 
consumed alcoholic beverages locally in Malaysia are beer and stout.  Special home-
brands such as toddy and samsu are used by the Indians and domestically manufactured 
rice alcohols are used by the indigenous people of Sarawak (Zain, 1999).  
 
 The mechanism of alcohol causing cancer has been difficult to establish. However, 
there have been studies suggesting the possible pathways of alcohol inducing 
carcinogenesis (Vecchia et al., 1997; Du et al., 2000; Figuero-Ruiz et al., 2004). Firstly, 
alcohol being a solvent by nature has its ability to dry the surface of the oral mucosa, thus 
increasing the permeability which leads to easier penetration of carcinogens into the oral 
mucosa (Das and Nagpal, 2002). For instance, concentrations of ethanol of 25% and above 
significantly increased the permeability of porcine oral mucosa to NNN (Du et al., 2000). 
Other than ethanol, there are some carcinogenic chemicals present in alcoholic beverages 
such as N-nitroso compounds, mycotoxins, urethane, inorganic arsenic and others (Blot, 
1992).  
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The major metabolite of alcohol is acetaldehyde whose transformation is mainly 
carried out by the enzyme alcohol dehydrogenase (ADH). Acetaldehyde is then oxidized to 
acetate by means of aldehyde dehydrogenase (ALDH). Acetaldehyde causes DNA damage 
in cultured mammalian cells. It interferes with DNA synthesis and repair. Acetaldehyde 
inhibits the enzyme 6-methylguanitransferase which is responsible for repairing injuries 
caused by alkylating agents. With all the above ill-effects of acetaldehyde which initiates 
or promotes tumor formation, increase in acetaldehyde accumulation in the body either due 
to increase in its production or due to decrease in its elimination, is considered harmful 
(Figuero-Ruiz et al., 2004). Accumulation of acetaldehyde can occur due to increased 
activity of ADH enzyme which is present in oral microflora and in the oral mucosa. Poor 
oral hygiene with increasing microbial flora can increase acetaldehyde accumulation. ADH 
type-3 genotypes cause rapid oxidation of alcohol to acetaldehyde and these individuals are 
more predisposed to oral cancer. Alternately, reduction in ALDH enzyme can also lead to 
accumulation of acetaldehyde (Figuero-Ruiz et al., 2004). Genetic polymorphisms have 
been reported in these two enzymes ADH and ALDH, which have been related to 
increased risk of alcohol-related cancers.  
 
2.2.3 Betel-quid chewing 
 
Several epidemiological studies have shown an association between the habit of 
betel-quid chewing and oral cancer and various precancerous lesions. The association has 
been consistent across many countries such as in India, Philippines, Malaysia, Bangladesh, 
Cambodia and Thailand (Saub, 2001). Among the Indians, chewing betel-quid with 
tobacco is the most widespread and has been demonstrated as a major risk factor for oral 
cancer (Gupta and Nandakumar, 1999).  
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Betel-quid chewing with different ingredients is the most common habit in 
Southeast Asia especially in the Indian subcontinent. Betel-quid (also referred to as pan or 
paan) usually consists of betel-leaf (leaf of Piper betel vine) that is wrapped around a 
mixture of cured or sun-dried areca nut (seed of Areca catechu), slaked lime (boiled from 
seashells) and tobacco (Kumar and Zain, 2004). The slaked lime lowers the pH and 
accelerates the release of an alkaloid from both the tobacco and areca nut, which produces 
a feeling of euphoria and well-being in the chewer (Johnson, 2001; Neville and Day, 
2002). Considerable research has been focused recently on the carcinogenic, mutagenic 
and genotoxic potential of betel-quid ingredients, especially tobacco and areca nut.   
 
In Malaysia, the single habit of chewing betel-quid was most popular among the 
Indian females (Ramanathan and Lakshimi, 1976). In a study conducted by Muttalib et al., 
(2002), it was reported that more than 22% of the population still practiced betel-quid 
chewing although it was now more confined to certain populations including Indians 
working in remote plantations, the indigenous people of Sabah and Sarawak and some 
elderly Malay folks living in rural villages (Zain and Ghazali, 2001). Most Chinese do not 
indulge in betel-quid chewing habit. Even after three decades, she reported that the higher 
proportion of females who chewed betel-quid remain the same while higher proportions of 
males tended to smoke and consume alcohol (Muttalib et al., 2002). 
 
Betel-quid chewing produces reactive oxygen species (ROS) that have multiple 
detrimental effects upon the oral mucosa. The ROS can be directly involved in the tumor 
initiation process, by inducing genotoxicity and gene mutation or by attacking the salivary 
proteins and oral mucosa. This will eventually lead to structural changes in the oral mucosa 
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that may facilitate the penetration by other betel-quid ingredients and environmental 
toxicants (Walker et al., 2003).  
 
2.2.4 Diet 
 
Apart from tobacco smoking, alcohol consumption and betel-quid chewing habits, 
several dietary factors have been related to oral cancer risk (Fioretti et al., 1999). 
Antioxidants which are contained in fruits and vegetables seem to have a preventive effect 
(Reichart, 2001; Boeing et al., 2006). Generally, antioxidants like vitamin A, C, E and β-
carotene scavenge potentially free radicals from damaged cells and are obtained in red, 
yellow and green fruits and vegetables (Reichart, 2001; Warnakulasuriya, 2002).  
 
Dietary factors seem to be important in the prevention of oral cancer as has been 
shown in a number of recent studies. A study by Prasad et al., (1995) suggested that the 
poor dietary intake of vegetables and fruits coupled with low estimated intake of beta 
carotene, thiamin, riboflavin, folate, vitamin C, iron, copper and high saturated fat intake 
(Fioretti et al., 1999) may modify the oral cancer risk potential. The combined effects of 
micro nutrients appear to be protective in countering the adverse effects of exogenous 
exposures to tobacco (Prasad et al., 1995). Donaldson (2004) in his study highlighted that 
abundant portions of fruits and vegetables lowered cancer risk. Allium and cruciferous 
vegetables are especially beneficial in cancer prevention, with broccoli sprouts being the 
densest source of sulforophane. Protective elements in a cancer prevention diet also 
include selenium, folic acid, vitamin B12, vitamin D, chlorophyll and antioxidants such as 
the carotenoids (beta carotene, lycopene, lutein).  
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2.2.4.1 Functional foods 
 
Food provides nutrients in infinite combinations and with unlimited variety. 
Functional foods can be defined as foods that provide health benefits beyond basic 
nutrition. Many fruits and vegetables fit into this category. For instance, broccoli and other 
cruciferous vegetables have been associated with a decreased cancer risk in 
epidemiological studies. Further research has shown that these vegetables contain a 
number of phytochemicals that have anticancer properties (Grosvenor and Smolin, 2002). 
 
2.2.4.2 Phytochemicals 
 
Phytochemicals are health-promoting compounds found in plant foods. These 
health-promoting properties have been recognized because of epidemiological observations 
that identified relationships between diets high in certain plant foods and a reduction in 
chronic disease such as cancer (Grosvenor and Smolin, 2002). Further evaluation of these 
foods has led researchers to specific phytochemicals that may be responsible for health 
benefits. Foods such as cruciferous vegetables and garlic have been found to be excellent 
sources of these health-promoting compounds. The phytochemicals found in these foods 
include indoles, isothiocyanates, dithiolthione and allium compounds (Craig, 1997). 
 
Most phytochemicals are found in more than one type of plant food and many have 
multiple actions within the body. Sulfides and isothiocyanates stimulate the activity of 
enzymes that help deactivate carcinogens (Grosvenor and Smolin, 2002). For the purpose 
of this study, phytochemical such as isothiocyanate and their food sources and mechanism 
of action are discussed here. 
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2.2.5 Human papilloma virus (HPV) 
 
HPV may play a role in the etiology of oral cancer (Warnakulasuriya, 2002). The 
exact role of HPV in oral cancer etiology still remains unclear. Williams (2000) in his 
study reported that HPV was found in 33-50% of oral cancer and mainly consist of HPV-
16 and HPV-18. In another study, HPV-16 and HPV-18, which are well known for their 
oncogenic potential in uterine cervix cancer, are present up to 80% in oral cancer 
(Reichart, 2001). 
 
The major evidence of the role of HPV in cancer development is that their genes 
and gene products are capable of disturbing the cell cycle machinery. HPV encodes two 
major oncoproteins namely, E6 and E7. The E6 and E7 proteins have been shown to bind 
and destroy p53 and pRb tumor suppressor genes respectively, thereby disrupting the cell 
cycle with loss of control on DNA replication, DNA repair and apoptosis 
(Warnakulasuriya, 2002). 
 
2.2.6 Genetic susceptibility 
 
Several important risk factors that may potentially increase oral cancer risk such as 
the use of tobacco, alcohol and betel-quid are all well recognized. However, despite the 
importance of these casual habits, relatively only a few people who practiced these habits 
actually develop cancer. Conversely, there are patients who develop oral cancer in the 
absence of such habits or other identifiable lifestyle or environmental etiologic factors. 
Therefore, these observations suggest that the importance of inherent genetic factors may 
play a role in the development of oral cancer (Scully et al., 2000).  
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Some patients appear susceptible to cancer because of an inherited trait which 
affects their ability or inability to metabolize carcinogens or procarcinogens (Scully et al., 
2000; Kumar and Zain, 2004). Individual susceptibility to cancer is likely to be modified 
by the genotype for enzymes involved in the activation or detoxification of carcinogens in 
the human body which was constantly exposed to the environmental risk factors. 
Differences in metabolic capacity due to inherent genetic differences in Phase I 
(cytochrome P450) and phase II (GST drug metabolizing and detoxifying enzymes) 
enzymes indicate that genetic constitution may predispose an individual towards cancer 
(Johnson, 2001; Das and Nagpal, 2002).  
 
For instance, in a comparative study of African American and white American 
patients with oral cancer in the United States, GSTM1 null genotype was found to carry a 
significantly high oral cancer risk among African Americans but not among whites (Park et 
al., 2000). The lack of significant associations between GSTM1 genotype and oral cancer 
risk in Caucasians was further confirmed by a study on GSTM1, GSTT1 and CYP1A1 in 
185 Netherlands head and neck cancer subjects unmatched to 207 control individuals 
(Oude Ophuis et al., 1998). 
 
Other than GSTs polymorphisms, there are genetic susceptibilities reported among 
Japanese subjects which include polymorphism of N-acetyltransferase 1 and a finding that 
NAT*10 allele had a significantly high relative risk of 5.9 for non-smokers and 3.1 for 
smokers (Katoh et al., 1998). Genetic polymorphism of aldehyde dehydrogenase-2, which 
eliminates acetaldehyde generated during alcohol metabolism was examined in 237 
Japanese alcoholics (Yokoyama et al., 1998), of whom 16 had SCC of oral cavity. Fifty 
percent who had SCC of oral cavity had the mutant ALDH2*2 allele, and the blood 
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concentration of acetaldehyde in the affected 16 subjects was 11 times greater than in the 
homozygotes, and in this subset, significantly more multiple primary tumors were found.  
 
Determination of the nature of these genetic factors would have enormous benefit, 
not only to at risk family members, who would thus take particular care to avoid other 
risks, but in unraveling the molecular mechanisms of oral carcinogenesis, opening the way 
to better prevention and treatment (Johnson, 2003b). 
 
 
2.3 Dietary isothiocyanates (ITCs) 
 
ITCs are a family of compounds derived almost exclusively from plants and found 
abundantly in vegetables (Zhang, 2004). ITCs are largely responsible for the characteristic 
hot, pungent flavors of salad vegetables such as radish, cress, mustard leaves and 
watercress, and contribute to the flavor of cooked cruciferous vegetables (IARC, 2004).  
 
All ITCs are characterized by the presence of an –N=C=S group, whose central 
carbon often is highly electrophilic. The biological activities of ITCs, perhaps their toxic 
effects, may be primarily mediated through the reaction of this carbon atom with cellular 
nucleophilic targets. It is believed that the side chains of ITCs may play secondary roles, 
for example, affecting the electrophilicity of the –N=C=S group, altering the steric 
hindrance to the reactive carbon atom, and controlling the lipophilicity of the molecule 
(Kolm et al., 1995; Meyer et al., 1995; Zhang et al., 1995). Some of the structures of ITCs 
found commonly in consumed cruciferous vegetables are as in Figure 2.2. 
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Figure 2.2: Structures of isothiocyanates and side-chain structures (R) found commonly in 
eaten cruciferous vegetables. 
(Source: IARC Handbooks of Cancer Prevention, Cruciferous Vegetables, Isothiocyanates 
and Indoles, Vol. 9, WHO, IARC Press, 2004) 
 
ITCs are synthesized and stored in plants as relatively stable precursors, known as 
glucosinolates (Fahey et al., 1997). When the plant cells are injured or damaged, by 
microbial attack, mechanical food processing or chewing, glucosinolates are released and 
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converted to ITCs by the action of enzyme myrosinase (Shapiro et al., 1998). Myrosinase 
is an enzyme that coexists with but is physically segregated from glucosinolates in normal 
plants cells (Zhang, 2004). Myrosinase catalyses the following reaction (Figure 2.3): 
 
 
 
 
 
 
 
 
 
Figure 2.3: Hydrolysis of glucosinolates to isothiocyanates. 
(Source: IARC Handbooks of Cancer Prevention, Cruciferous Vegetables, Isothiocyanates 
and Indoles, Vol. 9, WHO, IARC Press, 2004) 
 
During cooking of cruciferous vegetables (brassica), the glucosinolate-myrosinase 
system may be modified as a result of inactivation of plant myrosinase, loss of enzymic 
cofactors such as epithiospecifier protein, thermal breakdown and/or leaching of 
glucosinolates and their metabolites or volatilization of metabolites (Dekker et al., 2000). 
Cooking brassica affects the site of release of breakdown products of glucosinolates, which 
is the upper gastrointestinal tract following consumption of raw brassica containing active 
plant myrosinase. After consumption of cooked brassica devoid of plant myrosinase 
glucosinolates are hydrolysed in the colon under the action of the resident microflora 
(Rungapamestry et al., 2007). The digestive fate of glucosinolates may be further 
influenced by the extent of cell rupture during ingestion, gastrointestinal transit time, meal 
composition, individual genotype and differences in colonic microflora (Stahl et al., 2002). 
       Isothiocyanate 
(ITC) 
 27 
Thus, it is also important to determine the levels of ITCs in cooked vegetables that have 
been prepared in the usual ways by the studied populations (Jiao et al., 1998). 
 
The metabolism of ITCs is governed by the –N=C=S groups. ITCs are metabolized 
in vivo principally by the mercapturic acid pathway: an initial conjugation through the –
N=C=S group with glutathione (GSH), which takes place spontaneously but is further 
promoted by GST (Kolm et al., 1995; Meyer et al., 1995; Zhang et al., 1995), giving rise 
to the corresponding conjugates. The GSH conjugates then undergo further enzymatic 
modifications (modifications of the GSH portion) to form sequentially the 
cysteinylglycine-, cysteine- and N-acetylcysteine –conjugates, which are excreted in urine. 
 
 
 
 
 
 
 
 
 
 
 
Figure 2.4: Isothiocyanates are conjugated to glutathione by glutathione s-transferase 
(GST), metabolized sequentially by γ-glutamyl transpeptidase (GGT), cysteinylglycinase 
(CG) and N-acetyltransferase (AT) to form, ultimately, mercapturic acid, NAC, N-
acetylcysteine.  
(Source: IARC Handbooks of Cancer Prevention, Cruciferous Vegetables, Isothiocyanates 
and Indoles, Vol. 9, WHO, IARC Press, 2004) 
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2.3.1 Sources  
  
Cruciferous vegetables are the principle dietary source of ITCs, but the types of 
crucifers frequently consumed by humans are limited. Below are some examples of 
popular crucifers that are particularly rich in certain ITCs include broccoli, cauliflower, 
bak choy, cabbage, Brussels sprouts, kai lan, watercress and choy sum (Zhang, 2004). 
 
                        
 
Figure 2.5: Broccoli     Figure 2.6: Cauliflower 
(Source: http://en.wikipedia.org/wiki/Broccoli)                   (Source: http://en.wikipedia.org/wiki/Cauliflower) 
 
 
                        
 
Figure 2.7: Bak choy      Figure 2.8: Cabbage 
(Source: http://en.wikipedia.org/wiki/Bok_choy)                     (Source: http://en.wikipedia.org/wiki/Cabbage) 
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       Figure 2.9: Brussels sprouts    Figure 2.10: Kai lan 
(Source: http://en.wikipedia.org/wiki/Brussels_sprout)              (Source: http://en.wikipedia.org/wiki/Kai-lan) 
 
 
                         
 
Figure 2.11: Watercress    Figure 2.12: Choy sum 
(Source: http://en.wikipedia.org/wiki/Watercress)                 (Source: http://en.wikipedia.org/wiki/Choy_sum) 
 
2.3.2 Estimated dietary ITC intake 
 
 Many efforts had been made to obtain estimates of dietary intake of ITC. So far, 
only Jiao et al., (1998) in Singapore and Shapiro et al., (1998) in the USA had reported the 
total ITC concentration found in several cruciferous vegetables. The estimates however, 
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are only approximate as the concentrations of ITC vary considerably depending on the 
growing conditions, the cultivars, storage and preparations, as considerable amounts of 
glucosinolates can be lost during storage and processing (IARC, 2004). 
 
Table 2.1: Cruciferous vegetables and their total ITC contents 
Vegetables ITC contents, mean and range 
(μmol/100g wet weight) 
 
Broccoli (Brassica oleracea var. italica) 
 
38.6 (10.1 – 62.0) 
Cabbage (Brassica oleracea var. capitata) 
 
27.5 (11.9 – 62.7) 
Cauliflower (Brassica oleracea var. botrytis) 
 
11.6 (2.7 – 24.0) 
Choy sum (Brassica chinensis var. parachinensis) 
 
11.1 (3.5 – 23.4) 
Kai lan (Brassica var. alboglabra) 
 
15.4 (3.1 – 35.9) 
Watercress (Nasturtium officinale) 
 
81.3 (17.1 – 144.6) 
 
(Source: Jiao et al., 1998) 
 
To date, the most important known biological activity of ITCs is their ability to 
inhibit cancer development. Many ITCs are potent cancer chemoprotective agents in 
animal systems (Zhang, 2001). A distinctive feature of these cruciferous vegetables is their 
relatively high content of glucosinolates, which are converted in vivo to ITCs, indoles and 
nitriles by the enzyme myrosinase (Steinkellner et al., 2001). 
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2.4 Genetic polymorphisms 
 
Genetic polymorphisms are a form of mutation which occurs in more than 1% of a 
population. These polymorphisms also refer to the simultaneous occurrence in the 
population of genomes which gives rise to allelic variations (as seen either in alleles 
producing different phenotypes). Genetic polymorphisms are associated with a number of 
genes which code for enzymes involved in the metabolic activation or detoxification of 
carcinogens (Park et al., 2000). For example, polymorphisms of GSTM1 and GSTT1 genes 
involve deletion of alleles while the polymorphism of GSTP1 involves the amino acid 
substitution of isoleucine with valine. 
 
2.4.1 Glutathione s-transferases (GSTs) 
 
 Glutathione S-transferase (GST) is a family of genes which are involved in the 
metabolism of many xenobiotics, including an array of environmental carcinogens. Human 
GSTs comprise several subfamilies of isoenzymes: principally GSTM1, GSTT1 and 
GSTP1. These enzymes are involved in the detoxification of the activated metabolites of 
carcinogens (Hung et al., 1997; Scully et al., 2000). GSTM1 and GSTT1 genes can be 
indicated by non-null (presence) or null (absence) genotypes. As for GSTP1 gene, ile/ile or 
wild-type genotype referred to high activity of the enzyme while the ile/val or val/val 
genotypes (polymorphism) indicate low activity of the enzyme. Deletions in the GSTM1 
and GSTT1 genes can produce the null genotypes, which lead to absence of activity of 
these enzymes; similarly reduced activity of GSTP1 has been attributed to the low activity 
of ile/val and val/val alleles.  
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GSTs also are dimeric proteins that catalyze conjugation reactions between 
glutathione and tobacco smoke substrates, such as aromatic heterocyclic radicals and 
epoxides. Conjugation facilitates excretion and thus constitutes a detoxification step 
(Geisler and Olshan, 2001). This class of enzymes is therefore important for maintaining 
cellular genomic integrity and, as a result, may play an important role in cancer 
susceptibility. 
 
The GSTM1 gene locus has been mapped on chromosome 1p13.3. This gene was 
found to be related in susceptibility to squamous cell carcinoma of the head and neck 
(Geisler and Olshan, 2001). The GSTM1 enzyme play an important role in the 
detoxification of polycyclic aromatic hydrocarbons (PAHs) including the strong tobacco 
smoke carcinogen and benzo(α)pyrene (Park et al., 2000). In the detoxification step, 
GSTM1 enzymes help to catalyze the conjugation of glutathione to carcinogenic diol-
epoxide, derivatives from PAHs which will be excreted (Mannervik et al., 1988). 
Individuals who have null genotype for the GSTM1 gene will have no GSTM1 enzyme 
activity. Hence, it has been suggested that the lack of this enzyme may potentially increase 
cancer susceptibility because of a decreased inability to detoxify carcinogens such as 
benzo(a)pyrene-7,8-diol epoxide, the activated form of benzo(α)pyrene (Hashibe et al., 
2003). 
 
As for the GSTT1, its gene locus exists on chromosome 22q11.2. This GSTT1 
enzyme has high activity towards epoxy and peroxide compounds (Meyer et al., 1991) and 
metabolizes alkyl halides and lipid peroxides (Scully et al., 2000). GSTT1 enzyme is 
important in the detoxification of naturally occurring monohalomethanes, as well as the 
industrial compounds dichloromethane and ethylene oxide (Pemble et al., 1994). Because 
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these agents are widely used as methylating agents, fumigants, pesticides and solvents, 
polymorphisms involved in their metabolism may be of importance in the etiology of aero-
digestive cancers. Individuals who have null GSTT1 locus have no enzymatic functional 
activity (Geisler and Olshan, 2001). Lacking a functional GSTT1 enzyme reportedly 
cannot conjugate monohalomethanes found in tobacco smoke and may have greater 
susceptibility to chromosomal damage via sister chromatid exchanges. Accumulation of 
these carcinogens in the body may increase the cancer risk. 
 
The GSTP1 gene is located on chromosome 11q13 (Rossini et al., 2002; Cote et al., 
2005). GSTP1 is one of a family of GST isozymes which catalyze the addition of 
glutathione to a broad spectrum of chemical compounds including ethacrynic acid and 
acrolein, as well as potent carcinogens such as epoxides of PAHs (Ketterer et al., 1992). 
GSTP1 is the most abundant of the GST enzymes and has been shown to be ubiquitously 
expressed in most human tissues including the oral cavity (Sarkar et al., 1997). One 
polymorphism of GSTP1 is caused by a single base pair substitution, where (A) adenine is 
replaced by (G) guanine, leading to an amino acid substitution in which isoleucine (I105) 
is replaced by valine (V105) (Miller et al., 2003). The polymorphism of GSTP1 genotype 
will generally lower activity towards PAH diol epoxides, and thus, has been predicted to 
have lower detoxification potential and greater risk for cancer. 
 
2.4.1.2 Distribution of GSTs 
  
The distribution of polymorphisms related to GSTs has been reported in different 
populations, mainly in the Asian region. Table 2.2 summarizes the distribution of GST 
genotypes among the population. Except for the study in Korea and Singapore which only 
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consists of males and different races respectively, the studies for other GSTs polymorphic 
genotypes from various population were being gender and ethnic independent.  
 
Studies from Korea and Southern China have showed that the distribution of GST 
were similar between these two populations. This similarity was clearly seen in GSTM1 
null, GSTP1 ile/ile (wild-type), ile/val and val/val genotypes where the distribution among 
the Korean were 53.8%, 68.4%, 29.1% and 2.5% (Cho et al., 2005), respectively as 
compared to the Chinese from China with 54.3% (GSTM1 null), 60.7% (GSTP1 ile/ile – 
wild-type), 35.2% (GSTP1 ile/val) and 4.1% (val/val) (Zhong et al., 2006).  
 
Two studies from South India also found consistent distribution of GST ranging 
from 22.4% – 30.4% and 16.8% - 17.6% for GSTM1 null and GSTT1 null genotype, 
respectively (Naveen et al., 2004; V et al., 2006). The GSTT1 null distribution among the 
Indians was comparable between two countries namely India and Singapore. The similarity 
of GSTT1 null genotype was noted with 16.0% and 16.8% among the Indians in Singapore 
(Lee et al., 1995) and India, respectively. The consistency was also obvious for both 
GSTM1 and GSTT1 combined genotype, the distribution among the Indians in these 
countries recorded 5.0% (Singapore) and 4.6% (India).  
 
Despite the similarity among the Asian population, the distribution of the GST was 
found to differ between the Caucasian and the Asian group. This was especially noted in 
the distribution of GSTM1 null, GSTT1 null, GSTP1 (ile/ile – wild-type) and GSTP1 
(val/val) genotypes. The distribution of GSTM1 null and GSTP1 (val/val) genotypes tended 
to be higher among the Caucasian than the Asian population. Conversely, the distribution 
of GSTT1 null and GSTP1 (ile/ile – wild-type) genotypes was more obvious among the 
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Asian than the Caucasian population. The percentage of mean distribution of GSTM1 null 
and GSTP1 (val/val) genotypes among the Caucasian were 49.5% and 12.4%, respectively 
as compared to the Asian population of 38.2% (GSTM1 null) and 3.2% (GSTP1 val/val). 
As for the GSTT1 null and the GSTP1 (ile/ile – wild-type) genotypes, the mean distribution 
among the Asian population were 35.4% and 62.5%, respectively as compared to the 
Caucasian of 21.6% (GSTT1 null) and 46.4% (GSTP1 ile/ile – wild-type). 
 
Among the Brazilian (Caucasian), 42.1% of the individuals had GSTM1 null 
genotype, whereas 25.4% had the GSTT1 null genotype. The genotypic distribution of 
GSTP1 was 49.7% (ile/ile – wild type), 38.1% (ile/val) and 12.2% (val/val). Individuals 
with both GSTM1 and GSTT1 null genotype was 9.8% (Rossini et al., 2002).  
 
 In another Caucasian studies, it was interesting to note that the distribution of the 
GSTs genotypes among the US and the German populations were very similar. For 
instance, the distribution of GSTM1 null, GSTT1 null and GSTP1 (val/val) genotypes 
among the German were 47.3%, 18.5% and 11.3% respectively (Schneider et al., 2004). 
Meanwhile among the US population, the genotypic distribution was 47.4% (GSTM1 null), 
18.6% (GSTT1 null) and 13.1% for (GTSP1 val/val) genotypes (Cote et al., 2005). 
 
The only study done in Singapore this region that uses some of the subjects from 
Malaysia, found that the proportions of Chinese, Malays and Indians with the GSTT1 null 
genotype were 58%, 38% and 16% respectively. Meanwhile, the frequency of the 
combined GSTM1 and GSTT1 null genotype among Chinese, Malays and Indians were 
37%, 22% and 5% respectively (Lee et al., 1995). 
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Among the Chinese in China, the frequency of GSTM1 null genotype was 54.3% 
and the frequency of the GSTP1 ile/ile (wild-type), ile/val and val/val genotype was 
60.7%, 35.2% and 4.1%, respectively (Zhong et al., 2006). 
 
 In Thailand, the distribution of the GSTM1 null genotype in their population 
reported to be 30.2% which was similar with the study done in Southern India 
(Kietthubthew et al., 2001). Meanwhile, almost half of the Thai population (47.2%) 
consists of individuals with GSTT1 null genotypes. 
 
In the South India population study, 30.4% and 16.8% of the individuals lacked 
(null) of the GSTM1 and GSTT1 gene respectively. Meanwhile, 4.6% of these people 
lacked (null) of both the GSTM1 and GSTT1 (Naveen et al., 2004). In another study from 
the same region South India population by V et al., (2006), the GSTM1 and GSTT1 null 
genotype frequencies were found to be 22.4% and 17.6% respectively. The GSTP1 
genotype frequency was 58.4% for ile/ile – wild type, 38.4% for ile/val and 3.1% for 
val/val (V et al., 2006). 
 
Among Korean males, 53.8% of the individuals had the GSTM1 null genotype and 
54.3% had the GSTT1 null genotype. The genotypic distribution of GSTP1 was 68.4% for 
ile/ile – wild type, 29.1% for ile/val and 2.5% for val/val. Twenty-nine percent had the null 
genotype for both GSTM1/GSTT1 genes. As for the combination of 
GSTM1/GSTT1/GSTP1, the wild type frequency was 14.9% (Cho et al., 2006). 
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Table 2.2: Summary of distribution on GSTM1, GSTT1 and GSTP1 genotypes in normal population 
 
 
 
Population 
 
 
Sample 
size, n 
GSTM1 
null (%) 
GSTT1 
null (%) 
GSTM1 
& GSTT1 
null (%) 
GSTP1  
 
     ile/ile         
(wild-type)    ile/val        val/val 
      (%)            (%)            (%) 
GSTM1, 
GSTT1 & 
GSTP1 
wild-type 
(%) 
 
 
 
Reference 
Caucasian 
    Brazilian 
 
591 
 
42.1 
 
25.4 
 
9.8 
 
49.7 
 
38.1 
 
12.2 
 
- 
 
Rossini et al., (2002) 
    USA 290 47.4 18.6 - 37.9 49.0 13.1 - Cote et al., (2005) 
    Germany 622 47.3 18.5 - 47.9 40.8 11.3 - Schneider et al., (2004) 
    Italy 100 56.0 31.0 - - - - - Capoluongo et al., (2006) 
    Netherlands 207 51.7 20.3 11.1 - - - - Oude Ophuis et al., (1997) 
    France 172 52.3 15.7 - 50.0 37.2 12.8 - Jourenkova-Mironova et al., (1999) 
Asian 
    Singapore  
        Malay 
        Chinese 
        Indian 
 
 
167 
187 
152 
 
 
 
- 
- 
- 
 
 
38.0 
58.0 
16.0 
 
 
22.0 
37.0 
5.0 
 
 
- 
- 
- 
 
 
- 
- 
- 
 
 
- 
- 
- 
 
 
- 
- 
- 
 
Lee et al., (1995) 
 
    China 196 54.3 - 
 
- 
 
60.7 35.2 4.1 - 
 
Zhong et al., (2006) 
- Not Reported 
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Table 2.2: Summary of distribution on GSTM1, GSTT1 and GSTP1 genotypes in normal population (continue) 
 
 
 
Population 
 
 
Sample 
size, n 
GSTM1 
null (%) 
GSTT1 
null (%) 
GSTM1 
& 
GSTT1 
null 
(%) 
GSTP1  
 
 
     ile/ile         
(wild-type)      ile/val        val/val 
      (%)              (%)            (%) 
 
GSTM1, 
GSTT1 & 
GSTP1 
wild-type 
(%) 
 
 
 
 
Reference 
Asian     
    Thailand  
 
53 
 
30.2 
 
47.2 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
- 
 
 
Kietthubthew et al., (2001) 
    South Indian 517 30.4 16.8 4.6 - - - - Naveen et al., (2004) 
    South Indian 255 22.4 17.6 - 58.4 38.4 3.1 - V et al., (2006) 
    Korean (male) 1051 53.8 54.3 29.0 68.4 29.1 2.5 14.9 Cho et al., (2005) 
- Not Reported
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2.5 Dietary ITCs, GSTs and cancer prevention 
 
2.5.1 Metabolism of carcinogen 
 
Both genetic and environmental factors are involved in the development of cancer. 
The environment-gene interaction on carcinogenesis has been well demonstrated by phase 
I and II enzymes that are involved in the metabolism of carcinogens. These enzymes are 
often termed xenobiotic metabolizing enzymes (XMEs) and found mainly in the liver and 
also in the upper aerodigestive tract mucosa. Some of these enzymes are polymorphic in 
genotypes, with corresponding variation in their activities (Hung et al., 1997). Besides, 
some of these XMEs also strongly influence the individual’s biological responses to 
carcinogens by formation of DNA adducts. Hence, certain XME genotype may increase 
individual susceptibility to cancer through erroneous carcinogen exposure (Kumar and 
Zain, 2004). 
 
In our human metabolism pathway, phase I involves the ‘activation’ of the 
carcinogen by oxygenation. This is mainly performed through cytochrome P450 enzymes 
encoded by the CYP gene superfamily. Phase II enzymes is the detoxification step, in 
which the ‘activated’ carcinogen is rendered more hydrophilic, thus it is easily excretable 
(Miller et al., 2003). One of the most important detoxification enzyme systems is the 
glutathione s-transferase (GST) family of enzymes. Human GSTs enzymes can be 
subdivided into five main classes, alpha (α), mu (μ), pi (π), theta (θ) and zeta (ζ) (Cho et 
al., 2006). However, for the purpose of this study, GSTM1, GSTT1 and GSTP1 genes 
would be the main focus in the discussion. 
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An example of the involvement of phase I and II metabolism pathway are as 
follows: Metabolism of carcinogens such as benzo(α)pyrene involves a balance of 
activation steps that produces reactive intermediates and detoxification steps that produce 
water-soluble, excretable compounds. Activation is often mediated by the cytochrome 
P450 pathway and can result in the formation products known as DNA adducts. A person 
who does not have the ability to produce the GSTM1 enzyme potentially accumulates 
more DNA adducts through their inefficiency at excreting activated carcinogens such as 
7,8-diol-9,10-epoxide (Geisler and Olshan, 2001). Thus, this individual may pose to be 
highly susceptible to cancer risk. 
 
One study by Park et al., (1997) showed that the prevalence of the CYP1A1 
(ile/val) polymorphism [including both the (ile/val) and (val/val) genotypes] was 
significantly higher in cases as compared to controls (17.6% versus 7.6%, respectively; 
crude odds ratio 2.6, 95% CI 1.2 – 5.7). These results suggest that individuals with 
CYP1A1 exon 7 ile/val polymorphism genotypes are at risk for oral cancer, and that this 
risk may not be influenced by differences in exposure to tobacco smoke (Park et al., 1997). 
 
2.5.2 ITCs and GSTs as preventive agents against cancer 
 
Dietary carcinogens such as PAHs, heterocyclic amines (HAs) and nitrosamines 
require metabolic activation to cause DNA-damage and cancer. The activation of 
carcinogens is primarily catalysed by phase I enzymes such as cytochrome P450 
(Steinkellner et al., 2001). Protection can be accomplished by inhibition of activating 
enzymes and/or by induction of phase II which leads to detoxification and accelerated 
excretion of carcinogens. 
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Induction of phase II detoxification enzyme (GSTM1/GSTT1/GSTP1) is a 
powerful strategy for achieving protection against carcinogenesis, mutagenesis and other 
form of toxicity of electrophiles and reactive forms of oxygen. Since consumption of large 
quantities of fruit and vegetables is associated with a striking reduction in the risk of 
developing a variety of malignancies, it is of interest that a number of edible plants contain 
substantial quantities of compounds that regulate human enzymes of xenobiotic 
metabolism (Fahey et al., 1997). 
 
Many ITCs, which are available to human subjects mainly through consumption of 
cruciferous vegetables, demonstrate strong cancer-prevention activity in animal models 
(Hecht, 1999). Human studies also show an inverse association between consumption of 
ITC and risk of cancer in several organs. Zhang and Talalay (1998) in their study found 
that there is in-vitro and in-vivo evidence that ITCs are potent anticarcinogenic 
compounds. These anticarcinogenic properties of ITCs have been attributed to their ability 
to alter detoxification pathways (Zhang and Talalay, 1998; Hecht, 1999), leading to 
decreased activation of procarcinogens and increased excretion of carcinogens.  
 
It has been well established that ITCs can inhibit cancer development through 
multiple mechanisms (Zhang and Talalay, 1994; Hecht, 2000; Conaway et al., 2002; 
Zhang et al., 2007), including:  
(i) blocking DNA damage by both inhibition of carcinogen activation of phase I 
enzymes (mainly cytochrome P450) and detoxification of reactive carcinogens 
through induction of phase II enzymes (e.g. GSTs). The in vitro and in vivo 
findings with ITCs are supported by human studies; daily intake of 300g 
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Brussels sprouts or 300g red cabbage induced plasma GST (Steinkellner et al., 
2001). 
(ii) reducing oxidative stress by elevating and maintaining cellular antioxidants 
(iii) inhibiting cell proliferation 
 
Other effects, including anti-inflammation, anti-infection, and perhaps induction of 
differentiation also have been observed with some ITCs and may contribute to the overall 
cancer-preventive effects of these compounds. The ability of ITCs to simultaneously 
modulate multiple cellular targets involved in cancer development is of significant 
importance (Zhang, 2004).  These findings shed new light on the mechanism of action of 
ITC and indicate that ITC may be useful both as cancer-preventive and therapeutic agents.  
 
Specifically, ITCs are tasked to inhibit phase I activating enzymes, and induce 
phase II detoxification enzymes in various target tissues (Zhang and Talalay, 1994; Fahey 
et al., 1997; Hecht, 1999). ITCs, in particular exert their effects through the latter pathway. 
Induction of phase II detoxification enzymes reduces exposure of the target tissue to DNA 
damage, thus exerting a ‘blocking effect’ on the initiation stage of chemical carcinogenesis 
(Steinkellner et al., 2001; Rouzaud et al., 2004). ITCs and other phase II enzyme inducers 
can also act as ‘suppressing agents’ during the post-initiation stage of carcinogenesis by 
promoting apoptosis, and suppressing malignant transformation, possibly through their 
effect on the cellular glutathione pool (Grubben et al., 2001; Kirlin et al., 1999; Bonnesen 
et al., 2001). This dual action is thought to reduce the production of electrophilic 
intermediates with carcinogenic activity and to enhance the detoxification and clearance of 
carcinogens. 
 
 43 
ITCs are not only inducers of phase II enzymes but are also substrates for GSTs, 
which are phase II enzymes (Zhang et al., 1995). The enzyme-catalysed nucleophilic 
attack of the sulfhydryl group of glutathione on the central carbon of the ITC group results 
in the formation of glutathione dithiocarbamates that are modified by a sequence of 
enzymatic reactions, leading ultimately to the formation of N-acetlycysteine 
dithiocarbamates (also known as mercapturic acid). The glutathione adduct and its four 
sequential metabolic products are excreted in the urine, but the N-acetylcysteine 
mercapturic acids predominate (Shapiro et al., 1998). On the other hand, the GST enzymes 
also constitute an important part of cellular defense against reactive carcinogens or 
oxidants. Their protective functions are achieved by formation of polar (water soluble) 
conjugates of electrophile carcinogens that are easily excreted in the urine or bile, thus 
reducing the effective body burden of the carcinogen (Conaway et al., 2002; Zhang, 2004).  
 
As an initial reaction, GSTs catalyze the rather slow conjugation between GSH with 
the electrophiles, including genotoxic chemicals and ITCs (Conaway et al., 2002). Some 
ITCs are readily conjugated by human GSTM1 and GSTP1 but are slowly conjugated by 
other forms (Meyer et al., 1995; Zhang et al., 1995). The rates of catalytic conjugation of 
ITCs by various forms of GST depended very much on the structure of the ITCs. It is 
conceivable that ITC, as an inducer of GST, facilitates its own excretion by increasing its 
rate of conjugation with GSH (IARC, 2004). 
 
In a previous study by Zhang and Talalay, (1998) they showed that many ITCs 
rapidly accumulate in cells to very high concentrations (up to millimolar levels), and the 
accumulations appeared to play a critical role in determining their activites in inducing 
anticarcinogenic phase II enzymes. Subsequent studies showed that ITCs were principally 
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accumulated as GSH conjugates in cells and that cellular GSH might be the major driving 
force for ITC accumulation by undergoing rapid conjugation with the entering ITCs. 
Elevating cellular GSH levels also resulted in nearly proportional increases in cellular ITC 
uptake. Interestingly, lipophilicity of ITCs did not seem to influence ITC uptake by cells. 
Taken together, it is concluded that ITCs are taken up by cells predominantly, if not 
entirely, through GSH conjugation reactions in cells, and that cellular GST promotes ITC 
uptake by enhancing the conjugation reaction (Zhang, 2001). 
 
 
2.6 Dietary ITCs, GSTs polymorphisms and cancer risk 
 
2.6.1 Dietary ITCs and cancer risk 
 
Dietary ITCs may play an important role in the prevention of human cancers (Jiao 
et al., 1998). Epidemiological study provides evidence that the consumption of cruciferous 
vegetables protects against cancer more effectively than the total intake of fruits and 
vegetables.  
 
Epidemiologic studies have demonstrated inverse associations between crucifer 
intake and the incidence of lung, breast, bladder, prostate, stomach and colon cancer 
(Verhoeven et al., 1996). Prospective dietary assessment of 628 men diagnosed with 
prostate cancer found that increasing crucifer intake from 1 to 3 or more servings per week 
resulted in a 41% decreased apparent risk (Cohen et al., 2000). A 10-year cohort study of 
47,909 men reported that increased crucifer intake, but not fruits and other vegetables, was 
associated with decreased risk for bladder cancer (Michaud et al., 1999). Verhoeven and 
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co-workers also reviewed the results of 7 cohort studies and 87 case-control studies and 
reported that 67% of the case control studies found inverse associations between total 
crucifer intake and cancer risk (Verhoeven et al., 1996). Inverse associations between 
cancer risk and intakes of cabbage, broccoli, cauliflower or brussel sprouts were noted in 
70%, 56%, 67% and 29% of the control studies, respectively. The cohort studies showed 
inverse associations between intakes of cabbage, cauliflower or broccoli and risks for lung 
cancer; between total crucifer intake and risk for stomach cancer; and between broccoli 
intake and risk for all cancers. Although some reports have attributed to the protective 
activities of cruciferous vegetables to their glucosinolate content, other phytochemicals and 
constituents, i.e. carotinoids, vitamins, folic acid, selenium, dietary fiber, coumarins, 
flavonoids etc. may also contribute.  
 
In another study, human subjects with detectable urinary excretion of total ITCs 
were found to have much lower incidence of lung cancer (smoking-adjusted relative risk = 
0.65) than those with undetectable urinary ITCs (London et al., 2000). Despite the 
relationship between exposure to ITCs and human cancer risk being reported, not many 
have studied the effect of dietary ITCs on oral cancer. Only one study by Nair and Bartsch 
(2001) had identified ITC as the possible chemopreventive agents for cancer of the oral 
cavity. 
 
2.6.2 GSTs polymorphisms and cancer risk 
 
   The impact of genetic polymorphisms in GSTM1, GSTT1 and GSTP1 on the 
susceptibility to cancer has received particular interest since these enzymes play a central 
role in detoxification of major classes of tobacco carcinogens. There were many studies 
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done on the GSTs polymorphisms and the risk of cancers such as lung, esophageal, 
cervical, breast and bladder cancer. While some of these studies showed that GSTs 
polymorphisms could be the genetic determinant in the development of cancers, others find 
it otherwise. Table 2.3 summarizes the GSTs polymorphisms and cancer risks. 
 
 Among the Caucasians, some studies have shown that there was no association 
between GSTM1, GSTT1 and/or GSTP1 polymorphism and risk of lung cancer (Nazar-
Stewart et al., 2003; Wang et al., 2003; Schneider et al., 2004; Cote et al., 2005; Wenzlaff 
et al., 2005). However, Miller et al., (2003) in his study found that GSTP1 polymorphism 
increased the lung cancer risk associated with pack-years of smoking. Meanwhile, 
Sweeney et al., (2003) also discovered that GSTM1 null genotype confers susceptibility to 
lung cancer, although there was no similar association found between GSTT1 and GSTP1 
polymorphism.   
 
 In the Asian region, a study among the non-smoking Chinese in Hong Kong 
showed that GSTT1 null genotype was associated with an increased risk for lung cancer 
(OR 1.69, 95% CI 1.12-2.56) (Chan-Yeung et al., 2004). On the other hand, the population 
in the rural Thailand reported by Pisani et al., (2006) showed that GSTM1 null had no 
effect on the risk of lung cancer. 
 
A study done in China by Tan et al., (2000) demonstrated that GSTM1 null 
genotype could be a possible genetic determinant in the development of squamous cell 
carcinoma of the esophagus. On the contrary, Jain et al., (2006) reported that genetic 
polymorphisms of GSTM1, GSTT1 and GSTP1 were not associated with higher risk of 
esophageal cancer among the North Indian population. 
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 There was no overall association of the GSTM1 and GSTT1 null genotype with 
breast cancer risk, but the GSTP1 polymorphism (val/val) may be significant to breast 
cancer risk in the Asian populations (Egan et al., 2004). In another study done by Sobti et 
al., (2006) found that GSTM1, GSTT1 and GSTP1 was associated with an increase risk of 
developing cervix cancer among the passive smokers. Meanwhile, Srivastava et al., (2005) 
demonstrated that only GSTP1 (val/val) polymorphism was a strong predisposition risk 
factor for bladder cancer (OR 7.12, 95% CI 3.14-16.16). 
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Table 2.3: Summary of GSTM1, GSTT1 and GSTP1 polymorphisms and cancers risk 
 
 
 
Population 
 
Sample size, n 
   
Case   Control 
 
 
Site 
GSTM1 null 
 
 
↑ risk     NA 
GSTT1 null 
 
 
↑ risk     NA       
GSTP1 polymorphism  
(ile/val and/or val/val) 
    
 ↑ risk              NA   
 
 
Reference 
Caucasian  
    bUSA 
 
274 
 
501 
 
Lung 
 
- 
 
X 
 
- 
 
X 
 
- 
 
X 
 
Nazar-Stewart et al., (2003) 
    bUSA 582 600 Lung  - X  - X  - X  Wang et al., (2003) 
    bGermany 446 662 Lung - X  - X  - X  Schneider et al., (2004) 
    bUSA  350 410 Lung  - X  - X  - X  Cote et al., (2005) 
    aUSA 166 181 Lung - X  - X  - X  Wenzlaff et al., (2005) 
    bUSA 1042 1161 Lung - - - - X  - Miller et al., (2003) 
    fUSA  253 - Lung X  - - X  - X  Sweeney et al., (2003) 
Asian 
    aHong Kong 
 
229 
 
197 
 
Lung 
 
- 
 
X  
 
X  
 
- 
 
- 
 
X  
 
Chan-Yeung et al., (2004) 
    eThailand 211 211 Lung - X  - - - - Pisani et al., (2006) 
    bChina 150 150 Esophagus X  - - X  - X  Tan et al., (2000) 
    cNorth India 100 137 Esophagus - X  - X  - X  Jain et al., (2006) 
    dIndia  103 103 Cervix X - X - X - Sobti et al., (2006) 
    eChina  1144 1221 Breast - X  - X  X  - Egan et al., (2004) 
    eNorth India 106 370 Bladder - X  - X  X  - Srivastava et al., (2005) 
NA: no association; anever-smoker; bsmoker; cmixed habits – smoker & drinker; dpassive smoker, eunavailable 
- Not Reported
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2.6.3 GSTs polymorphisms and oral cancer risk 
 
Polymorphisms in the gene encoding the GSTs metabolizing enzyme have 
previously been associated with susceptibility to various cancers. Many studies have 
looked into the roles of GSTs polymorphisms with the oral cancer susceptibility, but the 
findings have been inconsistent. The following table 2.4 gives an overview of the GST 
polymorphisms and the risk of oral cancer. 
 
Some studies have shown that among the Caucasians, there was no association 
between GSTM1, GSTT1 and/or GSTP1 polymorphism and susceptibility to oral cancer 
risk (Park et al., 1997; Oude-Ophuis et al., 1998; Olshan et al., 2000; Hahn et al., 2002; 
Gronau et al., 2003). Meanwhile, no association was also observed between the GSTM1 
and GSTT1 null genotypes and oral cancer risk in Asian namely Taiwan, India and Japan 
(Hung et al., 1997; Sreelekha et al., 2001; Sugimura et al., 2006).  
 
 However, in a study from Italian Lazio region, Capoluongo et al., (2006) found that 
genetic alteration of GSTM1 detoxifying enzyme as a risk factor for the development of 
head and neck cancer (HNSCC). A meta-analysis done by Ye et al., (2004) also supported 
the hypothesis that GSTM1 (OR 1.27, 95% CI 1.13-1.42) and GSTT1 (OR 1.14, 95% CI 
1.00-1.31) were important risk factors for HNSCC and suggested that GSTM1 and GSTT1 
deficiency may have an effect on the risk of developing HNSCC. On another note, Morita 
et al., (1999) and Cho et al., (2006) reported that polymorphism (val/val) of GSTP1 were 
also associated with increased risk of HNSCC.  
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Several studies especially from the Asian populations strongly suggest that GSTM1 
null genotype as a risk factor for the development of oral cancer. A study done by Buch et 
al., (2002) among the Indians found that individuals with GSTM1 null genotype may have 
3 times the risk of developing oral cancer (OR 3.2, 95% CI 2.4-4.3). Similar risk was also 
observed in both Japanese (OR 2.2, 95% CI 1.4-3.6) and the Thailand population (OR 2.6, 
95% CI 1.04-6.50) (Sato et al., 1999; Kietthubthew et al., 2001). Another study by Cha et 
al., (2007) also supported that GSTM1 null genotype was highly susceptible and closely 
associated with increased risk of oral cancer in Koreans. GSTM1 null polymorphism has 
also been linked with an increased risk of oral cancer among Japanese and African-
American smokers (Trizna et al., 1995; Kihara et al., 1997). These studies are consistent 
with the previously observed metabolic activity of GSTM1 towards PAHs since these 
carcinogens are abundant in tobacco smoke (Ketterer et al., 1998). 
 
 Previous study by Jourenkova-Mironova et al., (1999) and Sharma et al., (2006) 
among the Caucasian smokers suggested that GSTP1 and GSTT1 gene polymorphisms 
modulate susceptibility to smoking-related cancers of the oral cavity. Sikdar et al., (2004) 
and Park et al., (1999) found that polymorphism (val/val) of GSTP1 was associated with 
oral cancer risk among Indian tobacco smokers and Caucasians light smokers respectively. 
On another note, Hashibe et al., (2003) found that the combination of GSTM1 null, GSTT1 
null and GSTP1 polymorphism genotypes conferring an OR of 2.06 (95% CI 1.11-3.81) 
were associated with higher risk of oral cancer. 
 
Because these carcinogen-metabolizing enzymes may be among numerous genes 
involved in the multistage pathway of cancer, they are expected to be modest to moderate 
risk factors that may be difficult to detect. However, even modest single gene effects on 
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cancer risk are of biological and medical importance because of the possibility of 
identifying, under multigenic models, high-risk individuals for target prevention activities 
(Hashibe et al., 2003). 
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Table 2.4: Summary of GSTM1, GSTT1 and GSTP1 polymorphism and oral cancer risk 
 
 
Country 
 
 
Sample size, n 
 
  Case      Control 
 
 
Site 
 
 
Population  
 
GSTM1 null 
 
 
↑ risk     NA 
 
GSTT1 null 
 
     
↑ risk     NA       
 
GSTP1 polymorphism  
(ile/val and/or val/val) 
 
   ↑ risk               NA      
 
 
 
Reference 
Caucasian  
    bUSA 
 
186 
 
42 
 
Oral  
 
White  
 
X  
 
- 
 
- 
 
X  
 
- 
 
- 
 
Trizna et al., (1995) 
    bUSA 135 135 Oral White  - X - - - - Park et al., (1997) 
    aUSA 104 
53 
175 
85 
Oral  White  
Black  
- 
- 
- 
- 
- 
- 
- 
- 
X 
- 
- 
- 
Park et al., (1999) 
    aUSA 112 
70 
174 
28 
Oral  White  
Black  
- 
- 
X 
- 
- 
- 
X 
- 
- 
- 
X 
- 
Olshan et al., (2000) 
   bNetherlands 185 207 Oral  Caucasian  - X - X - - Oude-Ophuis et al., (1998) 
    bGermany 94 92 Oral  Caucasian  - X - - - - Hahn et al., (2002) 
    bGermany  73 136 Oral  Caucasian  - X - X - - Gronau et al., (2003) 
    aFrance 121 172 Oral  Caucasian  - X X - X - Jourenkova-Mironova et al., 
(1999) 
    bItaly 80 80 HNSCC Caucasian  X - - X - - Capoluongo et al., (2006) 
NA: no association; asmoker; bunavailable 
- Not Reported 
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Table 2.4: Summary of GSTM1, GSTT1 and GSTP1 polymorphism and oral cancer risk (continue) 
 
 
Country  
 
Sample size, n 
 
 Case        Control 
 
 
Site 
 
 
Population  
GSTM1 null 
 
 
↑ risk    NA 
GSTT1 null 
 
     
↑ risk    NA     
GSTP1 polymorphism  
(ile/val and/or val/val) 
 
    ↑ risk             NA 
 
 
Reference 
Asian 
    dTaiwan 
 
41 
 
123 
 
Oral  
 
Chinese  
 
- 
 
X  
 
- 
 
X  
 
- 
 
- 
 
Hung et al., (1997) 
    eIndia 98 60 Oral  Indian  - X  - X  - - Sreelekha et al., (2001) 
    cJapan 122 241 Oral  Asian  - X  - X  - - Sugimura et al., (2006) 
    aIndia  40 87 Oral  Indian  - X  X  - - - Sharma et al., (2006) 
    aIndia  285 426 Oral  Indian  X  - - X  - - Buch et al., (2002) 
    aJapan 142 142 Oral  Asian  X  - - - - - Sato et al., (1999) 
    eThailand 50 
3 
53 
0 
Oral  Buddhist  
Muslim  
X  - - X  - - Kiettubthew et al., (2001) 
    aKorea 72 221 Oral  Asian  X  - - - - - Cha et al., (2007) 
    aJapan 158 474 Oral Asian  X  - - - - - Kihara et al., (1997) 
    aIndia  256 259 Oral  Indian  - X  - X  X  - Sikdar et al., (2004) 
    bJapan  145 164 HNSCC Asian  - X  - - X  - Morita et al., (1999) 
    aKorea 294 333 HNSCC Asian  - - - - X  - Cho et al., (2006) 
NA: no association; asmoker; bdrinker; cmixed habits – smoker & drinker; dmixed habits – smoker, drinker and chewer; eunavailable  
- Not Reported
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2.6.4 Dietary ITC intake and the association with GSTs polymorphisms and cancer 
risk 
 
The relationship between intake of ITCs and cancer appears to be complex, and 
there are individual differences in response to ITCs, which depend on variations in 
biotransformation enzymes (Ketterer, 1998). This gene-environment interaction has been 
best studied in relation to the genetic polymorphisms that affect GST expression (Hayes 
and Strange, 2000). GST catalyses the conjugation of glutathione to ITCs, and ITCs are 
among the substrates most rapidly conjugated by GST (Kolm et al., 1995). Because GSTs 
are also known to metabolize ITCs, this pathway results in the formation of N-
acetylcysteine conjugates, which are excreted in the urine (Brusewitz, 1977 and Jiao, 
1994). Based on the biological interaction between GST and ITCs, the beneficial effect of 
ITC is therefore dependent in part on the presence or absence of GST activity. Individuals 
with low activity or null for GST will metabolize these compounds at a slower rate and 
therefore less readily conjugate and excrete ITC. Thus, this would be expected to have 
greater amounts of ITC at the tissue level, and hence would experience a greater protective 
effect (Seow et al., 2005).   
 
Epidemiological studies have been designed to specifically evaluate dietary ITC 
consumption as a protective factor in human cancer. Table 2.6 summarizes dietary ITC 
intake and the association with GSTs polymorphisms and cancer risk. In one study, 
cruciferous vegetable consumption of 246 Singapore Chinese, 111 men and 135 women 
ages 45-74, was evaluated using cyclocondensation assay for daily total urinary ITC 
excretion (Jiao et al., 1998). It was proposed that GSTM1 null individuals would excrete 
ITCs more slowly because of insufficient activities of GSTs, but in this study there was no 
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significant difference (p = 0.61) in urinary excretion of ITCs between GSTM1 null and 
GSTM1 non-null subjects. Urinary excretion of ITCs was, however, significantly higher 
among GSTT1 non-null subjects relative to GSTT1 null individuals (p = 0.006). The 
strength of the association was highly dependent on the level of cruciferous vegetable 
consumption by study subjects. 
 
 Another study evaluated the direct relationship between total ITCs in urine, GST 
genotype, and subsequent risk for lung cancer among 232 incident cases of lung cancer and 
710 matched controls from a cohort of 18,244 men in Shanghai, China (London et al., 
2000). Individuals with ITCs in the urine were at a decreased risk for lung cancer. 
Interestingly, the protective effect of dietary ITCs was more pronounced in persons with 
the homozygous GSTM1 null genotype (relative risk 0.36, 95% CI 0.20-0.63) and was 
particularly strong in subjects with deletion of both GSTM1 and GSTT1 (relative risk 0.28, 
95% CI 0.13-0.57). It was hypothesized that the reduced rate of excretion of ITCs in 
persons lacking the specific genotype(s) for GSTs that conjugate ITCs may result in higher 
levels of ITCs in the body, thus, enhanced the chemopreventive effects of dietary ITCs. 
The results provide the first direct evidence that links dietary ITCs to reduced incidence of 
lung cancer in humans.  
 
A subsequent case-control study involving 503 cases of lung cancer and 465 
controls of American Whites was conducted by Spitz and colleagues (2000). Dietary ITCs 
were estimated on the basis of a questionnaire. The mean total ITC intakes were estimated 
to be 0.47+0.51mg/1000kcal for the cases and 0.58+0.84mg/1000kcal for the control. 
Cases of lung cancer reported a significantly lower ITC intake per day compared with 
controls (p = 0.009). Although there was no discernable effect on lung cancer incidence 
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associated with the GSTM1 null genotype, there was a statistically significant OR of 1.41 
associated with the GSTT1 null genotype. For current smokers with the GSTT1 null 
genotype, the OR with low ITC intake was 3.19 (95% CI 1.54-6.62); the comparable OR 
with low ITC intake for both GSTM1 null and GSTT1 null genotypes was 5.45 (95% 1.72-
17.22). However, these effects were not demonstrated for GSTM1 null, GSTT1 null and 
combined GSTM1 and GSTT1 null genotypes with the high ITC intake. The OR for 
GSTM1 null, GSTT1 null and combined GSTM1 and GSTT1 null genotypes with the high 
ITC intake were 1.55 (95% CI 0.79 – 3.04), 1.31 (95% CI 0.60 – 2.85) and 1.09 (0.38 – 
3.14), respectively and found to be not statistically significant.  
 
 Recently, another hospital-based case-control study evaluated the association 
between dietary ITC intake, GSTM1 and GSTT1 polymorphisms, lung cancer risk in 420 
Singapore Chinese women (Zhao et al., 2001). Dietary ITC intakes were estimated from a 
food frequency questionnaire and were relatively more objective because samples of the 
consumed vegetables were quantified for total ITC contents. Higher weekly intake of ITCs 
(above the control median value of 53.0µmol) reduced the risk of lung cancer to a greater 
extent in smokers (OR 0.31, 95% CI 0.10-0.98) than in non-smokers (OR 0.70, 95% CI 
0.45-1.11). Among non-smokers with GSTM1 null genotype, higher intake of ITCs 
significantly reduced the risk of lung cancer (OR 0.54, 95% CI 0.30-0.95); the effect was 
not observed in subjects with detectable GSTM1 (OR 1.07, 95% CI 0.50-2.29). The results 
were consistent with the hypothesis that ITC intake is inversely related to risk of lung 
cancer, but that among non-smokers, the effect is primarily confined to GSTM1 null 
individuals. Thus, three well-performed studies indicate that lung cancer risk is reduced by 
dietary sources of ITCs, and that person with the GSTM1 null and GSTT1 null genotypes 
clearly benefit more extensively from diets rich in ITCs.  
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 The protective effects of dietary ITCs against colon cancer have also been reported. 
Seow et al., (2002) compared 213 incident cases of colorectal with 1194 controls. The 
cases were identified through the population-based Singapore Cancer Registry involving 
63,257 men and women, who were enrolled from 1993 to 1998. Information on dietary 
ITC intake was collected at the recruitment via a semi-quantitative food frequency 
questionnaire. Dietary ITC intake was slightly lower in the cases (mean 5.4µmol/1000kcal) 
than the controls (6.0µmol/1000kcal), but the difference was not significant. Although 
there were no overall associations between GSTM1, GSTT1 or GSTP1 genotypes and 
colorectal cancer risk, there was a 57% reduction in risk among high (greater than median 
dietary ITC intake of 5.2µmol/1000kcal) versus low (less than/equal to median) consumers 
of ITC in individuals with both GSTM1 and GSTT1 null genotypes (OR 0.43), in particular 
for colon cancer (OR 0.31).   
 
 Another study by Wang et al., (2004) on the dietary intake of cruciferous 
vegetables, GSTs polymorphisms and lung cancer risk in a Caucasian population found 
that higher intakes of cruciferous vegetables reduced lung cancer risk among GSTM1 
present individuals (OR 0.61, 95% CI 0.39-0.95) but not among GSTM1 null individuals 
(OR 1.15, 95% CI 0.78-1.68). No significant interactions were observed for GSTT1 or the 
combined GSTM1/T1 genotype. 
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Table 2.5: Summary of dietary ITC intake and the association with GSTs polymorphisms and cancer risk 
 
 
 
 
Population 
 
 
 
Site 
High dietary ITC intake 
 
          GSTM1 null                         GSTT1 null               GSTM1 & GSTT1 null       GSTP1 polymorphism 
   ↓ risk                NA                ↓ risk              NA              ↓ risk               NA              ↓ risk             NA 
 
 
 
 
Reference 
Caucasian 
 
    USA 
 
 
Lung 
 
 
 
 
X  
 
 
X  
 
 
 
 
 
 
 
 
 
 
 
 
Spitz et al., 
(2000) 
    USA 
 
Lung   X   X   X    Wang et al., 
(2004) 
 
Asian 
 
    China 
 
 
Lung 
 
 
X  
    
 
X  
    
 
London et 
al., (2000) 
    Singapore Lung  X         Zhao et al., 
(2001) 
    Singapore  Colorectal  X   X  X    X  Seow et al., 
(2002) 
NA: no association 
